Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 0.1 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 0.21 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 0.12 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 0.09 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 0.08 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 0.11 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 0.08 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 0.09 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 0.0 | BCD100322A01 | 0.51 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 0.5 | BCD100322A03 | 0.33 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 1.0 | BCD100322A07 | 0.45 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 2.0 | BCD100322A11 | 0.37 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 4.0 | BCD100322A15 | 0.27 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 8.0 | BCD100322A19 | 0.15 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 12.0 | BCD100322A23 | 0.15 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | C | 24.0 | BCD100322A27 | 0.11 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 0.11 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 0.12 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 0.08 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 0.07 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 0.11 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 0.1 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | - | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 0.5 | BCD100322A04 | 0.56 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 1.0 | BCD100322A08 | 0.32 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 2.0 | BCD100322A12 | 0.29 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 4.0 | BCD100322A16 | 0.31 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 8.0 | BCD100322A20 | 0.14 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 12.0 | BCD100322A24 | 0.14 | pmol/sample |
| LMFA03010060 | 11β-PGE2 | 25OH-Chol | 24.0 | BCD100322A28 | 0.1 | pmol/sample |